US approves eye drops that could eliminate need for reading glasses

The US has approved a new type of eye drop which they say could eliminate the need for reading glasses

TItan Eye Plus
Representative image
IANS New York
2 min read Last Updated : Jul 14 2022 | 11:55 AM IST

The US has approved a new type of eye drop which they say could eliminate the need for reading glasses.

The FDA (Food and Drug Administration) recently approved the use of an eye drop designed to improve age-related near-vision, reports Express.co.uk.

Called Vuity, the drop is applied to each eye once a day and starts working within 15 minutes of application. The makers say each drop lasts for at least six hours.

As per the report, the drug is a formulation of a well-known compound known as pilocarpine.

The researchers behind Vuity designed it to allow for the eye drop to rapidly adjust to the pH of the tear film.

What the drop does is take advantage of the eye's ability to reduce pupil size, improve near-vision whilst maintaining distance vision.

The drop has been found to be most effective for those between the ages of 40 and 55.

Results have come from two randomised control trials on 750 subjects, the report said.

It was during these studies that Vuity was observed to start working within 15 minutes of application.

In a positive piece of news, the drops were found to result in no serious side effects. However, some patients experienced mild headaches and eye redness.

--IANS

vc/dpb

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :medicineUS FDA

First Published: Jul 14 2022 | 11:55 AM IST

Next Story